PROC Procaps Group, S.A.

Procaps Group, S.A. develops, manufactures, and markets over-the-counter (OTC) and prescription drugs, nutritional supplements, and clinical solutions. It operates in 13 countries in Latin America. The company was founded in 1977 and is based in Luxembourg City, Luxembourg

As of 12/02/2022     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Drug Manufacturers—Specialty &
Index country:  Luxembourg
Country of incorporation:  
IPO date:  12/09/2019
Outstanding shares:  112,824,183
Average volume:  35,080
Market cap:   $733,357,190
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
Valuation   (See tab for details)
PE ratio:   -13.36
PB ratio:   -19.61
PS ratio:   1.79
Return on equity:   269.69%
Net income %:   -24.62%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy